Balance Therapeutics Overview

  • Founded
  • 2009
  • Status
  • Out of Business
  • Employees
  • 3
  • Latest Deal Type
  • Out of Business

Balance Therapeutics General Information


Developer of pharmaceutical therapies designed to address neurological disabilities resulting from excess inhibition of the brain. The company's therapies offer a pharmacological approach to address cognitive deficits related to Down syndrome and Alzheimer's disease, enabling patients to get advanced therapy for their diseases and recover at a faster rate.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Delivery
Primary Office
  • 533 Airport Boulevard
  • Suite 400
  • Burlingame, CA 94010
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Balance Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 28-Oct-2020 000.00 Completed Out of Business
7. Later Stage VC 19-Mar-2019 0000 000.00 Completed Generating Revenue
6. Later Stage VC (Series C) 17-Feb-2016 0000 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series B) 19-May-2015 00.000 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series A) 18-Mar-2015 0000 0000 000.00 Completed Generating Revenue
3. Grant 01-Jan-2012 00.00 0000 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Feb-2011 $11M $11M 000.00 Completed Generating Revenue
1. Grant 01-Jan-2011 $363K Completed Generating Revenue
To view Balance Therapeutics’s complete valuation and funding history, request access »

Balance Therapeutics Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 13,469,555 $0.001000 $0.06 $1 $1 1x $1 25.11%
To view Balance Therapeutics’s complete cap table history, request access »

Balance Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial